EdgarLookup

Kim Lorence H.

Insider transactions at 3 companies

This page shows all SEC Form 4 filings attributed to Kim Lorence H.. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.

COR MRNA RVMDW
Company Title Type Shares Price Value Date
RVMDW Award / Grant 3,142 Jun 26, 2025
COR Award / Grant 789 Mar 6, 2025
RVMDW Award / Grant 4,248 Jun 20, 2024
RVMDW Award / Grant 4,800 Jun 20, 2024
COR Award / Grant 843 Mar 12, 2024
RVMDW Award / Grant 5,200 Jun 8, 2023
COR Award / Grant 1,334 Mar 9, 2023
0001466538 Disposition 30,000 $39.00 $1,170,000 Mar 1, 2023
COR Award / Grant 558 Nov 1, 2022
0001466538 Award / Grant 8,184 Aug 30, 2022
RVMDW Purchase 50,000 $20.00 $1,000,000 Jul 22, 2022
RVMDW Award / Grant 10,500 Jul 12, 2022
0001466538 Purchase 30,000 $30.03 $900,900 Feb 25, 2022
MRNA Chief Financial Officer Option Exercise 66,031 $19.15 $1,264,494 Jun 2, 2020
MRNA Chief Financial Officer Option Exercise 18,635 $12.21 $227,533 May 27, 2020
MRNA Chief Financial Officer Sale 7,640 $77.48 $591,947 May 18, 2020
MRNA Chief Financial Officer Sale 2,600 $63.80 $165,880 May 15, 2020
MRNA Chief Financial Officer Sale 61,412 $65.47 $4,020,644 May 12, 2020
MRNA Chief Financial Officer Sale 1,517 $35.81 $54,324 Apr 15, 2020
MRNA Chief Financial Officer Sale 2,792 $24.68 $68,907 Mar 16, 2020
MRNA Chief Financial Officer Sale 20,000 $27.71 $554,200 Mar 4, 2020
MRNA Chief Financial Officer Sale 745 $29.46 $21,948 Feb 26, 2020
MRNA Chief Financial Officer Sale 33,295 $23.06 $767,783 Feb 7, 2020
MRNA Chief Financial Officer Sale 23,805 $23.01 $547,753 Jan 28, 2020
MRNA Chief Financial Officer Sale 2,000 $23.04 $46,080 Jan 22, 2020
MRNA Chief Financial Officer Sale 89,698 $19.34 $1,734,759 Dec 6, 2019
MRNA Chief Financial Officer Gift 5,000 Sep 23, 2019
MRNA Chief Financial Officer C 458 Dec 11, 2018